$204.23 Million in Sales Expected for Ceridian HCM Holding Inc (CDAY) This Quarter

Equities research analysts predict that Ceridian HCM Holding Inc (NYSE:CDAY) will report $204.23 million in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Ceridian HCM’s earnings. The highest sales estimate is $204.50 million and the lowest is $204.00 million. Ceridian HCM posted sales of $208.90 million during the same quarter last year, which suggests a negative year-over-year growth rate of 2.2%. The firm is expected to announce its next earnings report on Tuesday, May 28th.

On average, analysts expect that Ceridian HCM will report full year sales of $814.23 million for the current fiscal year, with estimates ranging from $812.50 million to $816.40 million. For the next year, analysts forecast that the business will report sales of $921.40 million, with estimates ranging from $910.70 million to $951.90 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Ceridian HCM.

Ceridian HCM (NYSE:CDAY) last posted its quarterly earnings results on Wednesday, February 6th. The company reported $0.07 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.08 by ($0.01). Ceridian HCM had a negative net margin of 6.82% and a positive return on equity of 0.04%. The business had revenue of $200.30 million during the quarter, compared to analysts’ expectations of $196.56 million. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year.

Several brokerages have issued reports on CDAY. Goldman Sachs Group began coverage on shares of Ceridian HCM in a research report on Friday, February 1st. They issued a “neutral” rating and a $37.00 price objective for the company. Needham & Company LLC assumed coverage on Ceridian HCM in a research note on Thursday, January 3rd. They set a “buy” rating and a $40.00 target price on the stock. Zacks Investment Research raised Ceridian HCM from a “hold” rating to a “buy” rating and set a $56.00 target price on the stock in a research note on Friday, March 15th. Mitsubishi UFJ Financial Group lifted their target price on Ceridian HCM to $49.00 and gave the company an “overweight” rating in a research note on Thursday, February 7th. Finally, Piper Jaffray Companies reaffirmed an “overweight” rating and set a $50.00 target price on shares of Ceridian HCM in a research note on Thursday, February 7th. Eight analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $43.40.

In other news, EVP Lisa M. Sterling sold 11,250 shares of Ceridian HCM stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $49.84, for a total transaction of $560,700.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Arthur Gitajn sold 86,500 shares of Ceridian HCM stock in a transaction dated Wednesday, February 20th. The shares were sold at an average price of $47.01, for a total value of $4,066,365.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 14,364,892 shares of company stock valued at $703,169,802. 26.90% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in CDAY. Whale Rock Capital Management LLC grew its position in Ceridian HCM by 15.0% in the fourth quarter. Whale Rock Capital Management LLC now owns 3,927,540 shares of the company’s stock valued at $135,461,000 after acquiring an additional 512,067 shares during the period. Capital Research Global Investors lifted its holdings in shares of Ceridian HCM by 53.7% during the third quarter. Capital Research Global Investors now owns 2,920,293 shares of the company’s stock valued at $122,740,000 after purchasing an additional 1,020,293 shares during the last quarter. Vanguard Group Inc lifted its holdings in shares of Ceridian HCM by 3.1% during the third quarter. Vanguard Group Inc now owns 2,196,582 shares of the company’s stock valued at $92,323,000 after purchasing an additional 66,585 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Ceridian HCM by 3.1% during the third quarter. Vanguard Group Inc. now owns 2,196,582 shares of the company’s stock valued at $92,323,000 after purchasing an additional 66,585 shares during the last quarter. Finally, Partners Group Holding AG purchased a new position in shares of Ceridian HCM during the fourth quarter valued at approximately $62,981,000. Institutional investors and hedge funds own 80.11% of the company’s stock.

NYSE CDAY traded up $0.28 during mid-day trading on Friday, hitting $51.76. The company’s stock had a trading volume of 1,702 shares, compared to its average volume of 1,099,056. Ceridian HCM has a 52-week low of $28.65 and a 52-week high of $52.60. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market capitalization of $7.13 billion and a price-to-earnings ratio of -1,035.50.

About Ceridian HCM

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Further Reading: How to Invest in Growth Stocks

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.